Described herein are catalytic hydrogenation and the use of ruthenium complexes having a bidentate diphosphine ligand or two monodentate phosphine ligands, two carboxylate ligands, and optionally a diamine ligand in hydrogenation processes for the reduction of imines into the corresponding amines.

A method for producing a chiral metal oxide structure, involves a sol-gel step of allowing a transition metal compound having a bi- or higher dentate chelate ligand to act on a chiral supramolecular crystal of an acid-base complex containing a polymer having a linear polyethyleneimine skeleton and a chiral dicarboxylic acid compound having two carboxyl groups and four or more carbon atoms to form a metal oxide layer on a surface of the chiral supramolecular crystal; and a calcination step of thermally decomposing the organic chiral supramolecular crystal after the sol-gel step to generate a transition metal oxide structure composed of the metal oxide layer prepared with the supramolecular crystal as a template.

Described herein are catalytic hydrogenation and the use of ruthenium complexes having a bidentate diphosphine ligand or two monodentate phosphine ligands, two carboxylate ligands, and optionally a diamine ligand in hydrogenation processes for the reduction of imines into the corresponding amines.

The present disclosure provides a method for efficiently producing and providing compounds having a spirooxindole skeleton, for example compounds having a spirooxindole skeleton and having antitumor activity that inhibit the interaction between Mdm2 protein and p53 protein, or intermediates thereof, using an asymmetric catalyst. Compounds having optically active tricyclic dispiroindole skeletons are obtained through catalytic asymmetric 1,3-dipolar cycloaddition reaction using ketimine as a reaction substrate and using a chiral ligand and a Lewis acid.

The present disclosure provides a method for efficiently producing and providing compounds having a spirooxindole skeleton, for example compounds having a spirooxindole skeleton and having antitumor activity that inhibit the interaction between Mdm2 protein and p53 protein, or intermediates thereof, using an asymmetric catalyst. Compounds having optically active tricyclic dispiroindole skeletons are obtained through catalytic asymmetric 1,3-dipolar cycloaddition reaction using ketimine as a reaction substrate and using a chiral ligand and a Lewis acid.

The current invention relates a process for making and using a bulk catalyst precursor (i.e. no support material is added as such) comprising Ni and Mo and/or W and an organic component, wherein the molar ratio of C:(Mo+W) ranges from 1.5 to 10. The bulk catalyst precursor is prepared from a mixture of metal-precursors with an organic agent. The organic agent is partly decomposed to form a mixed metal-oxide/C phase which is in effect the bulk catalyst precursor. This bulk catalyst precursor (i) is effectively insoluble in water (ii) does not have any appreciable pore volume or surface area and (iii) does not contain a (nano)crystalline metal-oxide phase as characterized by XRD.

The invention relates to a process for the preparation of homogeneous hybrid inorganic-organic materials comprising dissolving and/or suspending and/or dispersing an inorganic and an organic material in a ionic liquid solvent to form an ionic solution and precipitating the inorganic and organic materials together to form a hybrid inorganic-organic precipitate material. The invention further relates to the homogeneous hybrid inorganic-organic precipitate material obtainable or obtained by the process, in particular carbon alumina hybrid material, to shaped articles like fibers and particles comprising said hybrid material and the use thereof for the manufacture ofor as a component incatalysts, sorbents, building and construction materials, packaging materials, paper materials, coatings and polymers.

Tin (II) glucarate is found to be effective alone and in combination with other tin compounds for catalyzing the reaction of carboxylic acids such as furan-2,5-dicarboxylic acid, terephthalic acid and adipic acid with alcohols such as the C1-C3 alcohols.

The present disclosure provides a method for efficiently producing and providing compounds having a spirooxindole skeleton, for example compounds having a spirooxindole skeleton and having antitumor activity that inhibit the interaction between Mdm2 protein and p53 protein, or intermediates thereof, using an asymmetric catalyst. Compounds having optically active tricyclic dispiroindole skeletons are obtained through catalytic asymmetric 1,3-dipolar cycloaddition reaction using ketimine as a reaction substrate and using a chiral ligand and a Lewis acid.

The present disclosure provides a method for efficiently producing and providing compounds having a spirooxindole skeleton, for example compounds having a spirooxindole skeleton and having antitumor activity that inhibit the interaction between Mdm2 protein and p53 protein, or intermediates thereof, using an asymmetric catalyst. Compounds having optically active tricyclic dispiroindole skeletons are obtained through catalytic asymmetric 1,3-dipolar cycloaddition reaction using ketimine as a reaction substrate and using a chiral ligand and a Lewis acid.